We found increased mRNA levels of p21 and a significant decrease in cell cycle-promoting proteins such as CDK2, CDK4, cyclin E1, and cyclin D1, suggesting a possible tumor-suppressing role of LCK in liver and lung cancers. This evidence concerns the gene CDKN1A and lung carcinoma.